Significance of lymphovascular space invasion in uterine serous carcinoma: What matters more; Extent or presence?

International Journal of Gynecological Pathology

Volumn 34, Issue 1, 2015, Pages 47-56

  Winer, Ira ^a   Ahmed, Quratulain F ^a   Mert, Ismail ^a   Bandyopadhyay, Sudeshna ^a   Cote, Michele ^a   Munkarah, Adnan R ^b   Hussein, Yaser ^b   Al Wahab, Zaid ^a   Elshaikh, Mohamed A ^b   Alosh, Baraa ^a   Schultz, Daniel S ^b   Mahdi, Haider ^b   Nucci, Marisa R ^b   Van DeVijver, Koen K ^b   Morris, Robert T ^a   Oliva, Esther ^b   Ali Fehmi, Rouba ^b  

^a WAYNE STATE UNIVERSITY   (United States)

^b HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

Lymphovascular space invasion; Uterine serous carcinoma

Indexed keywords

CARBOPLATIN; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNIC GROUP; FEMALE; HUMAN; INTERMEDIATE RISK PATIENT; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MYOMETRIUM; OUTCOME ASSESSMENT; OVERALL SURVIVAL; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; TUMOR INVASION; UTERINE SEROUS CARCINOMA; UTERUS CARCINOMA; CARDIOVASCULAR SYSTEM; CLINICAL TRIAL; LYMPHATIC SYSTEM; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, CYSTIC, MUCINOUS, AND SEROUS; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; UTERINE NEOPLASMS; UTERUS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR SYSTEM; FEMALE; HUMANS; LYMPHATIC SYSTEM; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, CYSTIC, MUCINOUS, AND SEROUS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; UTERINE NEOPLASMS; UTERUS;

EID: 84918811309     PISSN: 02771691     EISSN: 15387151     Source Type: Journal    
DOI: 10.1097/PGP.0000000000000113     Document Type: Article

References (31)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10-29.
2. Fader AN, Boruta D, Olawaiye AB, et al. Uterine papillary serous carcinoma: epidemiology, pathogenesis and management. Cur Opin Obstet Gynecol 2010;22:21-9.
3. Gadducci A, Cosio S, Landoni F, et al. Analysis of treatment failures and survival of patients with uterine papillary serous carcinoma: a Cooperation Task Force (CTF) Study. Int J Gynecol Cancer 2012;22:1355-60.
4. Moore KN, Fader AN. Uterine papillary serous carcinoma. Clin Obstet Gynecol 2011;54:278-91.
5. Slomovitz BM, Burke TW, Eifel PJ, et al. Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases. Gynecol Oncol 2003;91:463-9.
6. Narayan K, Khaw P, Bernshaw D, et al. Prognostic significance of lymphovascular space invasion and nodal involvement in intermediate- and high-risk endometrial cancer patients treated with curative intent using surgery and adjuvant radiotherapy. Int J Gynecol Cancer 2012;22:260-6.
7. Vance S, Yechieli R, Cogan C, et al. The prognostic significance of age in surgically staged patients with Type II endometrial carcinoma. Gynecol Oncol 2012;126: 16-9.
8. Kondalsamy-Chennakesavan S, Yu C, Kattan MW, et al. Nomograms to predict isolated loco-regional or distant recurrence among women with uterine cancer. Gynecol Oncol 2012;125:520-5.
9. Cohn DE, Horowitz NS, Mutch DG, et al. Should the presence of lymphvascular space involvement be used to assign patients to adjuvant therapy following hysterectomy for unstaged endometrial cancer? Gynecol Oncol 2002;87:243-6.
10. Hendrickson, M, Ross J, Eifel P, et al. Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol 1982; 6:93-108
11. Folkins AK, Nevadunsky NS, Saleemuddin A, et al. Evaluation of vascular space involvement in endometrial adenocarcinomas: laparoscopic vs abdominal hysterectomies. Mod Pathol 2010;23:1073-9.
12. Hart K, Han I, Deppe G, et al. Postoperative radiation for cervical cancer with pathologic risk factors. Int J Radiat Oncol Biol Physics 1997;37:833-8.
13. Ho CM, Chien TY, Huang SH, et al. Multivariate analysis of the prognostic factors and outcomes in early cervical cancer patients undergoing radical hysterectomy. Gynecol Oncol 2004;93:458-64.
14. Memarzadeh S, Natarajan S, Dandade DP, et al. Lymphovascular and perineural invasion in the parametria: a prognostic factor for early-stage cervical cancer. Obstet Gynecol 2003;102:612-9.
15. Unal OF, Ayhan A, Hosal AS. Prognostic value of p53 expression and histopathological parameters in squamous cell carcinoma of oral tongue. J Laryngol Otol 1999;113:446-50.
16. Beriwal S, Soran A, Kocer B, et al. Factors that predict the burden of axillary disease in breast cancer patients with a positive sentinel node. Am J Clin Oncol 2008;31:34-8.
17. Huang EH, Tucker SL, Strom EA, et al. Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy. Int J Radiat Oncol Biol Physics 2005;62:351-7.
18. Rouzier R, Preti M, Haddad B, et al. Development and validation of a nomogram for predicting outcome of patients with vulvar cancer. Obstet Gynecol 2006;107:672-7.
19. Raspagliesi F, Hanozet F, Ditto A, et al. Clinical and pathological prognostic factors in squamous cell carcinoma of the vulva. Gynecol Oncol 2006;102:333-7.
20. Yee DS, Shariat SF, Lowrance WT, et al. Prognostic significance of lymphovascular invasion in radical prostatectomy specimens. BJU Int 2011;108:502-7.
21. Keys HM, Roberts JA, Brunetto VL, et al. Gynecologic Oncology G: a phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2004;92:744-51.
22. Honore LH, Hanson J. Statistical analysis of pathologic risk factors for intramyometrial lymphvascular space involvement in myoinvasive endometrial carcinoma. Int J Gynecol Cancer 2006;16:1330-5.
23. Guntupalli SR, Zighelboim I, Kizer NT, et al. Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer. Gynecol Oncol 2012;124:31-5.
24. Briet JM, Hollema H, Reesink N, et al. Lymphvascular space involvement: an independent prognostic factor in endometrial cancer. Gynecol Oncol 2005;96:799-804.
25. Alektiar KM, McKee A, Lin O, et al. Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer? Int J Radiat Oncol Biol Physics 2002;54:79-85.
26. Fader AN, Starks D, Gehrig PA, et al. An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC). Gynecol Oncol 2009;115:244-8.
27. Hachisuga T, Kaku T, Fukuda K, et al. The grading of lymphovascular space invasion in endometrial carcinoma. Cancer 1999;86:2090-7.
28. Sakuragi N, Hareyama H, Todo Y, et al. Prognostic significance of serous and clear cell adenocarcinoma in surgically staged endometrial carcinoma. Acta Obstet Gynecol Scand 2000;79:311-6.
29. Kwon JS, Qiu F, Saskin R, et al. Are uterine risk factors more important than nodal status in predicting survival in endometrial cancer? Obstet Gynecol 2009;114:736-43.
30. Mohammed RA, Martin SG, Gill MS, et al. Improved methods of detection of lymphovascular invasion demonstrate that it is the predominant method of vascular invasion in breast cancer and has important clinical consequences. Am J Surg Pathol 2007;31:1825-33.
31. Kitchener H, Swart AM, Qian Q, et al. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 2009;373:125-36.